Top 10 Highest Valued Pharmaceutical Firms in 2023

Top 10 Highest Valued Pharmaceutical Firms in 2023

1: Eli Lilly (United States)

Market Cap $553 billion / Global Market Cap Share 7.9%

2: Novo Nordisk (Denmark)

Market Cap $461 billion / Global Market Cap Share 6.6%


3: Johnson & Johnson (United States)

Market Cap $377 billion / Global Market Cap Share 5.4%


4: Merck (United States)

Market Cap $276 billion / Global Market Share 3.9%



5: Abbvie (United States)

Market Cap $273 billion / Global Market Cap Share 3.9%



6: Roche (Switzerland)

Market Cap $234 billion / Global Market Cap Share 3.3%




7: AstraZeneca (United Kingdom)

Market Cap $209 billion / Global Market Cap Share 3.0%


8: Novartis (Switzerland)

Market Cap $207 billion / Global Market Cap Share 2.9%


9: Pfizer (United States)

Market Cap $162 billion / Global Market Cap Share 2.3%




10: Amgen (United States)

Market Cap $154 billion / Global Market Cap Share 2.2%


Ahmed E. Mousa, MBA, MSc

?? Entrepreneur | Product Marketing Expert | Go-To-Market & Brand Strategist | Helping Beauty & Wellness Brands Scale | AI-Enabled Product Marketing | HealthTech

1 年

Thanks for sharing Michael Meegan

Rajkumar Nair

Helping Pharma Professionals find Clarity & Purpose | Pharma Consultant | Leadership Coach

1 年

Great to see that one of the Highest valued pharma also was valued high in best place to work in 2023 . That makes sense as how strategies , tactics & employee engagement/ delight impacts external stakeholders

  • 该图片无替代文字
Nancy Bassillios

Head of Quality- Egypt and North East Africa

1 年

Very interesting thanks for sharing

要查看或添加评论,请登录

Michael Meegan - Strategic Hiring Partner - SearchMode的更多文章

社区洞察

其他会员也浏览了